Comparing Two Surfactants for Premature Babies With Breathing Problems
Part of Lungs & breathing, Women’s health & pregnancy clinical trials.
This trial compares two types of surfactant (Calfactant and Poractant Alfa) given through a less invasive method to very premature babies with breathing problems. It aims to see if one works better at helping them breathe without needing a breathing tube.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born at a participating hospital.
- Your baby is between 24 weeks and 1 day and 29 weeks and 6 days of pregnancy (before 30 weeks).
- Your baby is less than 6 hours old.
- Your baby is on breathing support without a breathing tube (like CPAP or similar).
- Your baby has been diagnosed with respiratory distress syndrome (RDS) based on symptoms and chest X-ray.
- Your baby needs extra oxygen (more than 30%) to keep oxygen levels in the target range (90-94%).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at different ways doctors give a life-saving medication called surfactant to premature babies who are struggling to breathe. Researchers want to understand which delivery methods work best and help improve care.
This study compares two ways of giving surfactant (a natural substance that helps lungs stay open) to premature babies who need extra breathing support. It aims to find which method works better and is safer for infants born at 29 to 36 weeks.
This trial tests if giving surfactant (a natural substance that helps lungs stay open) through a special airway device can help late preterm and early term infants with breathing problems. The goal is to see if this approach works better than current methods without needing a breathing tube.
This trial tests whether giving surfactant (a foam that helps lungs stay open) before breathing problems start can help very premature babies (born before 30 weeks) breathe better. It might reduce the need for a breathing tube.
This trial tests whether giving surfactant (a substance that helps lungs stay open) to premature babies with Respiratory Distress Syndrome (RDS) through a mask on the throat (supraglottic airway) is safe and effective. It may be an option for babies who need extra oxygen but are not on a breathing tube.
This study tests a new medicine called APC-0101, a type of surfactant, for premature babies with breathing problems (respiratory distress syndrome). It may help their lungs work better and reduce the need for more breathing support.
Hear when a new Surfactant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.